Redefining Efficiency

To Optimize Global Impact

Cactus Life Sciences provides scientific content across the healthcare continuum, anywhere in the world – with a focus on Science, Innovation, and Efficiency.

What we do

We lead with science to deliver impactful medical strategies and content. We are transforming the way scientific content is created and communicated. Whether it’s a custom operational model, scalable digital innovation, modular content or the use of AI, CACTUS is driven to provide you with the value and impact you desire.

Count on us to support you where you are today and to partner with you as you become future-ready.

Clinical Trial Phase

EXPLORE & UNDERSTAND
Pharma companies that involve patients early increase their chances of regulatory & commercial success.
Pre-Market/DSE
EXPAND & SOLIDIFY
A disease state awareness platform should be in market 9-12 months prior to launch to optimize impact.

Post-Marketing

ENGAGE & ADAPT
A human+AI driven future transforms the way scientific content is created, disseminated, and measured.
Pre-clinical
evaluation
Phase I
Phase IIA
Phase IIB
Phase III
Registration
and launch
Phase IV
Post-marketing
surveillance
Mature
brands

Cactus Life Sciences Evolution

Cactus Life Sciences acquired nspm and eluSCIdate. nspm’s rare disease expertise and global event proficiency expand Cactus Life Sciences’ services amidst an exciting buy-and-build strategy.

From where you are to where you’re going…
Cactus Life Sciences is there.

Expertise where it counts

There’s a reason that global organizations trust us with their business.

MEDICAL WRITING EXPERTS

CLIENTS

THERAPEUTIC AREAS

MOLECULES

Trusted partners

acadia-logo
amgen
astellas-logo
astrazeneca-logo
atara-bio-logo
boehringer-ingelheim-logo
bristol-myers-squibb-logo
covis-pharma-logo
csl-vifor-logo
eqrx-logo
gsk-logo
johnson-and-johnson-logo
karyopharm-therapeutics-logo
kyowa-kirin-logo
melinta-therapeutics-logo
merck-logo
merz-logo
moderna-logo
novartis-logo
novo-nordisk-logo
pharmacosmos-logo
proctor-and-gamble-logo
ptc-therapeutics-logo
shionogi-logo
takeda-logo
united-therapeutics-logo

Thought leadership that matters

We don’t just stay ahead of the curve. We create it.

Empowering Medical Affairs by Leveraging Modular Content

Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content

In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
plain language summaries and genAI

Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)

PLS play an important role in increasing the accessibility of medical publications to a wide...
Audiovisual medical publication content and formats

Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now 

GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...

Ready to REDEFINE efficiency?